Penn Medicine's "ImmunoRevolution" began over 20 years ago, when Carl June, MD, and his team began creating personalized immunotherapy treatments to reprogram the immune system to recognize and kill cancer cells.

At the time, there were limited funding opportunities for novel ideas like these and our researchers relied on philanthropy to fuel innovation.

Today, after years of hard work and tremendous support from amazing organizations and philanthropists, we have received FDA approval for the first-ever CAR T-cell therapy treatment.

This is just the beginning, and it is already revolutionizing how the world treats cancer. It has even led to studies in diabetes, cardiology and Parkinson's -- and will eventually extend to many other diseases as well.

Although the breakthrough has arrived, we still have a long way to go. We need more partners – more revolutionaries – to join the fight so that Penn's Abramson Cancer Center can design more treatments that put more patients' cancer into remission.

Donate now: [ Ссылка ]
Read the ImmunoRevolution Brochure: [ Ссылка ]
Learn more about immunotherapy: pennmedicine.org/immunotherapy

#immunotherapy #PennMedicine #ImmunoRevolution

свернуть